Dr Rabindera Nath Mehrotra

Dr. Rabinder Nath Mehrotra is a distinguished endocrinologist with over 29 years of experience, currently practicing at Apollo Hospitals, Jubilee Hills, Hyderabad. Dr. Mehrotra specializes in managing a wide range of endocrine disorders, including diabetes mellitus (types 1 and 2), metabolic bone diseases, pituitary and parathyroid disorders, adrenal disorders, and growth hormone deficiencies.  His clinical interests also encompass osteoporosis, metabolic bone diseases, and diabetes management.

Educational Qualifications:

• MBBS – MLN Medical College, Allahabad (1987)
• MD in Internal Medicine – 1988-1991
• DM in Endocrinology – Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Lucknow (1993–1996)
• DNB in Endocrinology – National Board of Examinations
• Clinical Densitometrist Certification – International Society for Clinical Densitometry (2022)

Professional Experience:

• Senior Consultant, Department of Endocrinology & Diabetes, Apollo Hospitals, Jubilee Hills, Hyderabad (1996 – Present)
• Senior Resident – Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Lucknow – Research & Training
• Clinical Laboratory Expertise – RIA (Radioimmunoassay), ELISA (Enzyme-Linked Immunosorbent Assay), IRMA (Immunoradiometric Assay)
• Academic Experience – Introduction to DNA Extraction & PCR, MLN Medical College, Allahabad – Teaching Undergraduates and Emergency Care

Notable Achievements

• First Prize for Poster Presentation in the RSSDI (Research Society for the Study of Diabetes in India) Paper of Honor in the Third Professional (MBBS) in the subject of Obstetrics and Gynaecology (OBG).

Professional Memberships

• Endocrine Society (USA)
• American Society for Bone and Mineral Research (ASBMR)
• Endocrine Society of India
• Research Society for the Study of Diabetes in India (RSSDI)
• Life Member of Indian Society Of Bone Mineral And Research (ISBMR)
• Member of Pediatric and Adolescent Endocrinology Chapter of IAP

Research Experience

• A Multicentric, Randomized, Double-blind, 3+2 year Trial in Osteoporosis– “PEARL TRIAL”. (Published- Title: Lasafoxifene in postmenopausal women with osteoporosis, NEJM, Volume- 362, Pg- 686-696, 2010)

• A Multicentric, Randomized, Double-Blind, 5-year Trial in Osteoporosis– “GENERATIONS TRIAL”

• A Multicentric -A Phase 2B Long-Term, Randomized, Open-Label Safety and Tolerability Trial Comparing with routine care in patients with chronic painful Diabetic peripheral neuropathy.

• A Multicentric, Randomized Trail on Osteoporosis Phase 3, Open-Label Trial for Parathyroid Hormone. (A Randomized Control Open labeled study in India)

• A Multicentric Phase 3 Trial Randomized, Double-Blind- Comparison of Two different Statins in patients with Type II Diabetes Mellitus.

• A Multicentric Phase 4 Trial Randomized– For Type II Diabetes Mellitus -The Durability of Twice Daily Insulin Lispro low mixture compared to once-daily Glargine in patients with type-2 Diabetes and inadequate Glycemic control. Published

Published

• A Multicentric Phase 3 Trial, Randomized, Double-Blind- Comparing the Efficacy and safety of a fixed combination of fenofibrate and metformin vs Metformin alone in subjects with type 2 diabetes mellitus and dyslipidemia not appropriately controlled with a statin.

• A Multicentric Phase 3 Trial, Durable Trial Randomized-For Type- 2 DM – Comparison of Premixed Insulin Lispro Low Mixture and Mid Mix regimens with separate Bolus Insulin Injections in a patient with inadequate glycemic. control on OHA who consume light breakfast

• Diabetic peripheral neuropathy- Neuropathic Pain: “A Cross-Sectional Survey of Burden of illness”.

• A Multicentric Phase 3 Trial Randomized “A Phase 2/3, Placebo-Controlled, Efficacy and Safety Study of Once-Weekly, Subcutaneous LY2189265 Compared to Sitagliptin in Patients with Type 2 Diabetes Mellitus on Metformin.

• International Growth Database survey.

• A randomized, open-label, parallel-group, multi-center trial comparing the efficacy and safety of 2 devices one injection device to another transaction device of growth hormone in children with idiopathic growth hormone deficiency.

• International Diabetes Management Practices Study.‍

Publications

ORIGINAL ARTICLES

• Extra Hepatic Portal Venous Obstruction in Children: Anthropometry, Growth hormone and Insulin-like Growth Factor-1. Mehrotra RN, Bahtia V, Dabadghao P, Yachha SK. Journal of Pediatric Gastroenterology and Nutrition. Nov 25 (5) 520-23. 1997.

• B Cell Function and Insulin Sensitivity in Tropical Calcific Pancreatitis from North India. Mehrotra R.N, Bhatia E, Chaudhari G. Metabolism 46(4), 441-44, April 1997.

• Growth Charts Suitable for evaluation of Indian children. Bhagwat, Dabadghao P, Mehrotra RN, Bhatia V. Indian Pediatrics, Sep 35(9) 859- 65.1998.

• Ectopic ACTH syndrome due to Bronchial Carcinoid Tumor. A case report. 1998, 35(2) 73-6.

• The Clinical Spectrum of Fibro Calculous Diabetes in North India. Mittal N, Mehrotra R N, Agarwal G, Rajeswari, Choudari G, Sikora S, Bhatia E. Natl Med J India 2002 Nov-Dec; 15(6): 327-31

• Ectopic ACTH syndrome due to Bronchial Carcinoid Tumor. A case report. 1998, 35(2) 73-6.

REVIEW ARTICLE

• Coronary Heart Disease in Diabetes. Role of hyperglycemia and hyperinsulinemia. Mithal A, Mehrotra R.N. International Journal of Diabetes in Developing Countries. Vol 15(3) 1995.